Investor Presentaiton

Investor presentation Full year 2018 Slide 77 The GLP-1 segment accounts for 3% of total diabetes care market value in Region AAMEO DKK billion Region AAMEO GLP-1 market VictozaⓇ Exenatide VictozaⓇ value market share in Region AAMEO VictozaⓇ Exenatide Dulaglutide Lixisenatide Dulaglutide Share of total diabetes care GLP-1 value market share GLP-1 market value market 2% 100% 80% 60% 1% 40% 20% 0% 0% Nov Nov 2018 2013 0.8 0.7 CAGR value¹: 24.2% 0.6 0.5 0.4 0.3 0.2 0.1 0.0 Nov 2013 1 CAGR for 5-year period AAMEO: Africa, Asia, the Middle East and Oceania Source: IQVIA monthly MAT Nov, 2018 value figures changing diabetes Source: IQVIA monthly MAT Nov, 2018 value figures Nov 2018 .43% 30% 27% novo nordisk

View entire presentation